Cliff Asness’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Cliff Asness’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-33,431	Closed	-$1.79M	–	2361
2016 Q1	$1.79M	Buy	33,431 +2,498	+8%	+$184K	﹤0.01%	1306
2015 Q4	$3.5M	Buy	30,933 +9,821	+47%	+$1.08M	0.01%	1023
2015 Q3	$2.48M	Buy	21,112 +1,757	+9%	+$229K	0.01%	1048
2015 Q2	$1.5M	Sell	19,355 -15,975	-45%	-$1.05M	﹤0.01%	1319
2015 Q1	$2.04M	Sell	35,330 -4,700	-12%	-$200K	﹤0.01%	1097
2014 Q4	$1.29M	Sell	40,030 -6,600	-14%	-$198K	﹤0.01%	1536
2014 Q3	$1.14M	Sell	46,630 -20,500	-31%	-$417K	﹤0.01%	1548
2014 Q2	$1.19M	Buy	67,130 +5,500	+9%	+$88.5K	﹤0.01%	1570
2014 Q1	$1.23M	Buy	61,630 +12,500	+25%	+$242K	﹤0.01%	1588
2013 Q4	$824K	Buy	+49,130	New	+$680K	﹤0.01%	1818

Other funds holding ANAC

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Cliff Asness's ANAC Position: Q2 2016 in Review

Cliff Asness sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 33,431 shares — an estimated $1.79M sold.

Cliff Asness first reported a position in ANAC in Q4 2013 and held it in 10 quarters. The position peaked at $3.5M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Cliff Asness reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Cliff Asness sold 33,431 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.79M.
Cliff Asness first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 10 quarters.
Cliff Asness's ANACOR PHARMACEUTICALS INC COM position peaked at $3.5M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on AQR Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.